Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Shanu Modi

13PUBLICATIONS
83CO-AUTHORS
Clinical midwiferyCancer therapy (excl. chemotherapy and radiation therapy)Models of care and place of birthMolecular targetsSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

Sort by Publication Date:
|Nov 10, 2025
Trastuzumab Deruxtecan Resistance via Loss of HER2 Expression and Binding.

Wanyi Chen, Avantika Gupta, Nicholas Mai

|Oct 08, 2025
Trastuzumab deruxtecan in HER2-low metastatic breast cancer: long-term survival analysis of the randomized, phase 3 DESTINY-Breast04 trial.

Shanu Modi, William Jacot, Hiroji Iwata

|Mar 25, 2025
Treatment patterns and outcomes in HER2-low metastatic breast cancer patients previously treated with chemotherapy: a US real-world cohort study.

Shanu Modi, Suyuan Zhang, Danalyn Byng

|Aug 02, 2024
Author Correction: Management of patients with advanced-stage HER2-positive breast cancer: current evidence and future perspectives.

Antonio Marra, Sarat Chandarlapaty, Shanu Modi

|Jan 09, 2024
Management of patients with advanced-stage HER2-positive breast cancer: current evidence and future perspectives.

Antonio Marra, Sarat Chandarlapaty, Shanu Modi

|Oct 18, 2022
Trastuzumab Deruxtecan in HER2-Positive Metastatic Breast Cancer Patients with Brain Metastases: A DESTINY-Breast01 Subgroup Analysis.

Guy Jerusalem, Yeon Hee Park, Toshinari Yamashita

Pageof 3

Frequent Collaborators

4 joint publications

Sarat Chandarlapaty

2 joint publications

Antonio Marra

2 joint publications

Toshinari Yamashita

2 joint publications

Joshua Z Drago

1 joint publications

Milan Grkovski

1 joint publications

Larry Norton

1 joint publications

Pedram Razavi

1 joint publications

Clifford A Hudis

1 joint publications

Jason S Lewis

1 joint publications

Montserrat Carrasco-Triguero

Frequent Collaborators

4 joint publications

Sarat Chandarlapaty

2 joint publications

Antonio Marra

2 joint publications

Toshinari Yamashita

2 joint publications

Joshua Z Drago

Top Related Videos

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
08:59

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on : Dec 11, 2017

7.5K
Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
13:19

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Published on : Apr 26, 2024

3.7K
See more related videos

Top Related Videos

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
08:59

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on : Dec 11, 2017

7.5K
Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
13:19

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Published on : Apr 26, 2024

3.7K
See more related videos